Variant report

Variant	nsv883212
Chromosome Location	chr5:177790952-177820134
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:141)
CpG islands
(count:610)
Chromatin interactive
region (count:20)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:141 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:177801961-177802199	K562	blood:	n/a	n/a
2	CEBPB	chr5:177791758-177792149	MCF-7	breast:	n/a	chr5:177791997-177792010
3	CHD2	chr5:177807188-177807205	HepG2	liver:	n/a	n/a
4	CHD2	chr5:177811271-177811417	H1-hESC	embryonic stem cell:	n/a	n/a
5	CTCF	chr5:177806840-177806990	GM12868	blood:	n/a	n/a
6	CTCF	chr5:177801991-177802042	GM12878	blood:	n/a	n/a
7	CTCF	chr5:177801940-177802090	K562	blood:	n/a	n/a
8	CTCF	chr5:177801985-177802101	MCF-7	breast:	n/a	n/a
9	CTCF	chr5:177795560-177795710	K562	blood:	n/a	n/a
10	CTCF	chr5:177807080-177807230	GM12868	blood:	n/a	n/a
11	CTCF	chr5:177795480-177795630	NB4	blood:	n/a	n/a
12	CTCF	chr5:177818054-177818127	MCF-7	breast:	n/a	n/a
13	CTCF	chr5:177801924-177802130	MCF-7	breast:	n/a	n/a
14	CTCF	chr5:177795440-177795590	HepG2	liver:	n/a	n/a
15	CTCF	chr5:177818040-177818101	MCF-7	breast:	n/a	n/a
16	CTCF	chr5:177801907-177802119	K562	blood:	n/a	n/a
17	CTCF	chr5:177802000-177802046	HepG2	liver:	n/a	n/a
18	CTCF	chr5:177811999-177812127	H1-hESC	embryonic stem cell:	n/a	chr5:177812054-177812067 chr5:177812052-177812070 chr5:177812058-177812067
19	CTCF	chr5:177801700-177801850	MCF-7	breast:	n/a	n/a
20	CTCF	chr5:177792140-177792290	SK-N-SH_RA	brain:	n/a	n/a
21	CTCF	chr5:177818018-177818107	MCF-7	breast:	n/a	n/a
22	CTCF	chr5:177818429-177818472	LNCaP	prostate:	n/a	n/a
23	CTCF	chr5:177801860-177802010	MCF-7	breast:	n/a	n/a
24	CTCF	chr5:177811920-177812070	GM06990	blood:	n/a	chr5:177812054-177812067 chr5:177812052-177812070 chr5:177812058-177812067
25	CTCF	chr5:177801940-177802122	MCF-7	breast:	n/a	n/a
26	CTCF	chr5:177812060-177812210	HL-60	blood:	n/a	n/a
27	CTCF	chr5:177801994-177802084	MCF-7	breast:	n/a	n/a
28	CTCF	chr5:177812020-177812170	HEK293	kidney:	n/a	chr5:177812054-177812067 chr5:177812052-177812070 chr5:177812058-177812067
29	CTCF	chr5:177818043-177818110	LNCaP	prostate:	n/a	n/a
30	CTCF	chr5:177802005-177802053	Hela-S3	cervix:	n/a	n/a
31	CTCF	chr5:177818069-177818101	LNCaP	prostate:	n/a	n/a
32	CTCF	chr5:177811980-177812130	SK-N-SH_RA	brain:	n/a	chr5:177812054-177812067 chr5:177812052-177812070 chr5:177812058-177812067
33	CTCF	chr5:177818572-177818621	GM10266	blood:	n/a	n/a
34	CTCF	chr5:177811980-177812130	WERI-Rb-1	eye:	n/a	chr5:177812054-177812067 chr5:177812052-177812070 chr5:177812058-177812067
35	CTCF	chr5:177801863-177802144	T-47D	breast:	n/a	n/a
36	CTCF	chr5:177812020-177812170	GM12865	blood:	n/a	chr5:177812054-177812067 chr5:177812052-177812070 chr5:177812058-177812067
37	CTCF	chr5:177801860-177802010	HepG2	liver:	n/a	n/a
38	CTCF	chr5:177818027-177818131	MCF-7	breast:	n/a	n/a
39	CTCF	chr5:177801840-177802190	K562	blood:	n/a	n/a
40	CTCF	chr5:177801806-177802224	MCF-7	breast:	n/a	n/a
41	CTCF	chr5:177801987-177802094	MCF-7	breast:	n/a	n/a
42	CTCF	chr5:177812000-177812150	GM12864	blood:	n/a	chr5:177812054-177812067 chr5:177812052-177812070 chr5:177812058-177812067
43	CTCF	chr5:177816400-177816550	SK-N-SH_RA	brain:	n/a	n/a
44	CTCF	chr5:177801940-177802090	MCF-7	breast:	n/a	n/a
45	E2F4	chr5:177798200-177798400	MCF10A-Er-Src	breast:	n/a	n/a
46	E2F6	chr5:177811192-177811338	K562	blood:	n/a	n/a
47	EBF1	chr5:177808953-177809280	GM12878	blood:	n/a	chr5:177809130-177809139 chr5:177809128-177809141
48	EP300	chr5:177791206-177792477	SK-N-SH	brain:	n/a	n/a
49	EP300	chr5:177791739-177792318	SK-N-SH_RA	brain:	n/a	n/a
50	EP300	chr5:177791743-177792347	SK-N-SH_RA	brain:	n/a	n/a

(count:610 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:177811198-177811248	NHBE	bronchial:	n/a
2	chr5:177811648-177811698	T-47D	breast:	n/a
3	chr5:177809164-177809214	SAEC	small airway:	n/a
4	chr5:177799357-177799407	U87	brain:	n/a
5	chr5:177809164-177809214	SK-N-SH_RA	brain:	n/a
6	chr5:177805003-177805053	Hela-S3	cervix:	n/a
7	chr5:177805003-177805053	NH-A	brain:	n/a
8	chr5:177810294-177810344	AG04450	lung:	fetal
9	chr5:177810294-177810344	HEK293	kidney:	embryo
10	chr5:177819485-177819535	PANC-1	pancreas:	n/a
11	chr5:177810294-177810344	HPAEpiC	pulmonary alveolar:	n/a
12	chr5:177799205-177799255	SAEC	small airway:	n/a
13	chr5:177811349-177811399	SKMC	muscle:	n/a
14	chr5:177811648-177811698	Caco-2	colon:	n/a
15	chr5:177799357-177799407	HRE	kidney:	n/a
16	chr5:177810294-177810344	Hela-S3	cervix:	n/a
17	chr5:177809164-177809214	HRPEpiC	eye:	n/a
18	chr5:177819485-177819535	HL-60	blood:	n/a
19	chr5:177810294-177810344	A549	lung:	n/a
20	chr5:177809164-177809214	NT2-D1	testis:	n/a
21	chr5:177811198-177811248	Hepatocyte	liver:	n/a
22	chr5:177799205-177799255	K562	blood:	n/a
23	chr5:177799357-177799407	HPAEpiC	pulmonary alveolar:	n/a
24	chr5:177809164-177809214	NHDF-neo	bronchial:	n/a
25	chr5:177814702-177814752	NB4	blood:	n/a
26	chr5:177799205-177799255	AG09309	skin:	n/a
27	chr5:177799205-177799255	CMK	blood:	n/a
28	chr5:177814702-177814752	A549	lung:	n/a
29	chr5:177814702-177814752	K562	blood:	n/a
30	chr5:177811648-177811698	RPTEC	kidney:	n/a
31	chr5:177811648-177811698	HRE	kidney:	n/a
32	chr5:177811648-177811698	PFSK-1	brain:	n/a
33	chr5:177811349-177811399	AG10803	skin:	n/a
34	chr5:177809164-177809214	HL-60	blood:	n/a
35	chr5:177810294-177810344	ovcar-3	ovarian:	n/a
36	chr5:177811349-177811399	Jurkat	blood:	n/a
37	chr5:177819485-177819535	SK-N-SH_RA	brain:	n/a
38	chr5:177811349-177811399	SK-N-SH_RA	brain:	n/a
39	chr5:177811349-177811399	AG09319	gingival:	n/a
40	chr5:177814702-177814752	HRE	kidney:	n/a
41	chr5:177799205-177799255	H1-hESC	embryonic stem cell:	embryo
42	chr5:177810294-177810344	HEEpiC	esophagus:	n/a
43	chr5:177814702-177814752	PrEC	prostate:	n/a
44	chr5:177814702-177814752	SK-N-SH_RA	brain:	n/a
45	chr5:177805003-177805053	HCM	heart:	n/a
46	chr5:177811648-177811698	Hepatocyte	liver:	n/a
47	chr5:177810294-177810344	HMEC	breast:	n/a
48	chr5:177810294-177810344	U87	brain:	n/a
49	chr5:177810294-177810344	ECC-1	luminal epithelium:	n/a
50	chr5:177819485-177819535	NB4	blood:	n/a

(count:20 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:177811102..177812638-chr5:177817501..177819406,2	K562	blood:
2	chr5:177806047..177808844-chr5:177816962..177819431,2	K562	blood:
3	chr5:177811102..177814167-chr5:177815792..177819406,4	K562	blood:
4	chr5:177799370..177801920-chr5:177806975..177809019,2	MCF-7	breast:
5	chr5:177806047..177808844-chr5:177816962..177819431,2	K562	blood:
6	chr5:177811102..177812638-chr5:177817501..177819406,2	K562	blood:
7	chr5:177786537..177789455-chr5:177802501..177804616,2	K562	blood:
8	chr5:177808919..177811059-chr5:177815128..177817359,2	K562	blood:
9	chr5:177777429..177779459-chr5:177792254..177794069,2	MCF-7	breast:
10	chr5:177808919..177811059-chr5:177815128..177817359,2	K562	blood:
11	chr5:177793010..177795271-chr5:177803266..177804910,2	K562	blood:
12	chr5:177804316..177806496-chr5:177806617..177809077,2	K562	blood:
13	chr5:177784139..177785777-chr5:177788896..177791858,2	K562	blood:
14	chr5:177793010..177795271-chr5:177803266..177804910,2	K562	blood:
15	chr5:177790380..177792280-chr5:177796021..177798764,2	K562	blood:
16	chr5:177816543..177819082-chr5:177820341..177823036,2	K562	blood:
17	chr5:177790380..177792280-chr5:177796021..177798764,2	K562	blood:
18	chr5:177799370..177801920-chr5:177806975..177809019,2	MCF-7	breast:
19	chr5:177804849..177806989-chr5:177807066..177809838,2	MCF-7	breast:
20	chr5:177811102..177814167-chr5:177815792..177819406,4	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-HNRNPAB-6	chr5:177804925-177805219	NONHSAT105532

No data

Variant related genes	Relation type
RN7SL646P	TF binding region
RN7SL646P	CpG island
ENSG00000242341	chromatin interactions
ENSG00000253698	chromatin interactions

Extended variants
information (count: 1464 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:1464 , 50 per page) page: 1 2 3 4 5 6 7 ... 30

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10464069	chr5:177790952-177790953	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs577116934	chr5:177790987-177790988	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs141086050	chr5:177791036-177791037	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs561024375	chr5:177791079-177791080	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs573078102	chr5:177791084-177791085	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs189432290	chr5:177791113-177791114	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs115837823	chr5:177791140-177791141	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs114477164	chr5:177791143-177791144	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs181475074	chr5:177791144-177791145	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs564003747	chr5:177791225-177791226	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs531147125	chr5:177791226-177791227	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs146936221	chr5:177791232-177791233	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs567475893	chr5:177791237-177791238	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs534912142	chr5:177791241-177791242	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs10213827	chr5:177791276-177791277	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs183602140	chr5:177791299-177791300	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs58171276	chr5:177791368-177791369	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs372351889	chr5:177791385-177791386	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs80137025	chr5:177791407-177791408	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs188327381	chr5:177791417-177791418	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs181901880	chr5:177791424-177791425	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs536503081	chr5:177791425-177791426	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs374973202	chr5:177791427-177791428	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs554924362	chr5:177791439-177791440	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs55892432	chr5:177791453-177791454	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs368237278	chr5:177791454-177791455	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs186590785	chr5:177791472-177791473	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs540466081	chr5:177791474-177791475	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs79731413	chr5:177791547-177791548	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs578069769	chr5:177791552-177791553	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs188988708	chr5:177791553-177791554	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs563497399	chr5:177791577-177791578	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs530819656	chr5:177791597-177791598	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs549240446	chr5:177791641-177791642	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs561264306	chr5:177791643-177791644	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs528648629	chr5:177791693-177791694	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs372516763	chr5:177791694-177791695	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs546819095	chr5:177791713-177791714	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs181869102	chr5:177791734-177791735	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs538396464	chr5:177791763-177791764	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs553873828	chr5:177791782-177791783	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs138615922	chr5:177791814-177791815	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs536268375	chr5:177791815-177791816	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs12109608	chr5:177791831-177791832	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs573201745	chr5:177791842-177791843	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs533970920	chr5:177791893-177791894	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs75631034	chr5:177791932-177791933	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs576974979	chr5:177791944-177791945	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs149372128	chr5:177791958-177791959	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs557452564	chr5:177791994-177791995	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Thyroid cancer	19087340	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sotos syndrome	21572526	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Sotos syndrome	17561922	CNVD
Sotos syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Sotos syndrome	22470819	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Acute myeloid leukemia	18000384	CNVD
Sudden cardiac death	19188705	CNVD
Basal cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Lung cancer	17297452	CNVD
Cancer	20164920	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Sotos syndrome	22283845	CNVD
Breast cancer	16272173	CNVD
Sotos syndrome	20503325	CNVD
Lung adenocarcinoma	17086460	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	19181860	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Ehlers-danlos syndrome	17576883	CNVD
Lung cancer	17086460	CNVD
Autism	19246517	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:456 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:177784400-177796800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
2	chr5:177784400-177798200	Weak transcription	Right Atrium	heart
3	chr5:177785200-177792000	Weak transcription	HUES6 Cell Line	embryonic stem cell
4	chr5:177785200-177798200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
5	chr5:177785600-177792200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
6	chr5:177787000-177791800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
7	chr5:177787200-177798200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
8	chr5:177789200-177791600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
9	chr5:177789200-177795800	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr5:177789400-177791200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr5:177789400-177791400	Weak transcription	HUES48 Cell Line	embryonic stem cell
12	chr5:177789400-177791400	Enhancers	Fetal Muscle Leg	muscle
13	chr5:177789400-177792800	Weak transcription	Thymus	Thymus
14	chr5:177789600-177791800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
15	chr5:177790200-177792600	Enhancers	Fetal Thymus	thymus
16	chr5:177790400-177791600	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
17	chr5:177790600-177791600	Enhancers	Spleen	Spleen
18	chr5:177790600-177793400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
19	chr5:177790800-177791000	Enhancers	Monocytes-CD14+_RO01746	blood
20	chr5:177790800-177791800	Enhancers	Lung	lung
21	chr5:177790800-177792000	Enhancers	Primary monocytes fromperipheralblood	blood
22	chr5:177790800-177792000	Enhancers	Primary neutrophils fromperipheralblood	blood
23	chr5:177790800-177792400	Enhancers	Cortex derived primary cultured neurospheres	brain
24	chr5:177790800-177794200	Enhancers	Placenta	Placenta
25	chr5:177791000-177791200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
26	chr5:177791000-177791400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
27	chr5:177791000-177791400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
28	chr5:177791200-177791800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
29	chr5:177791200-177791800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
30	chr5:177791200-177793200	Bivalent Enhancer	Fetal Stomach	stomach
31	chr5:177791200-177795000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr5:177791400-177791600	Enhancers	Primary hematopoietic stem cells short term culture	blood
33	chr5:177791400-177792000	Enhancers	Fetal Lung	lung
34	chr5:177791400-177792000	Enhancers	Dnd41	blood
35	chr5:177791400-177792000	Enhancers	Monocytes-CD14+_RO01746	blood
36	chr5:177791400-177792600	Bivalent Enhancer	Fetal Muscle Leg	muscle
37	chr5:177791600-177793000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
38	chr5:177791600-177794600	Weak transcription	Spleen	Spleen
39	chr5:177791800-177792000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
40	chr5:177791800-177792400	Enhancers	Fetal Brain Male	brain
41	chr5:177791800-177793000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
42	chr5:177792000-177792400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
43	chr5:177792000-177793400	Enhancers	HUES6 Cell Line	embryonic stem cell
44	chr5:177792000-177794000	Weak transcription	Fetal Lung	lung
45	chr5:177792000-177794600	Weak transcription	Dnd41	blood
46	chr5:177792200-177792400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr5:177792200-177792800	Enhancers	ES-I3 Cell Line	embryonic stem cell
48	chr5:177792200-177795400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
49	chr5:177792400-177793000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
50	chr5:177792400-177795600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links